Browsing Tag
Lupin
81 posts
Lupin to acquire rights to Brovana and Xopenex HFA for $75m
Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate)…
Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer
Indian pharmaceutical company Lupin announced that Dr. Shahin Fesharaki has been appointed as Global Chief Scientific Officer who…
Lupin partners with procurement agencies for TB prevention treatment
Lupin Limited has entered into partnerships with Unitaid, the Clinton Health Access Initiative (CHAI), The Aurum Institute, and…
Lupin launches generic Suprep Bowel Prep Kit in the US after FDA approval
Lupin launches FDA-approved generic Suprep Bowel Prep Kit in the US, entering a $202M market and expanding its gastrointestinal portfolio.
Lupin secures Health Canada approval for Enbrel biosimilar – Rymti
Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor…
Lupin bags UK approval for Lutio inhalation product for COPD treatment
Lupin through its subsidiary — Lupin Healthcare (UK) has secured approval from the UK Medicines and Healthcare products…
Lupin Diagnostics opens reference laboratory in Guwahati
Lupin said that its recently created diagnostics business — Lupin Diagnostics has opened its reference laboratory in Guwahati…
Lupin Diagnostics opens first reference laboratory in Kolkata
Lupin Limited said that its recently created diagnostics business — Lupin Diagnostics has opened its first reference laboratory…
Lupin secures FDA approval to launch generic vigabatrin oral solution in the US market
Lupin secures US FDA approval for generic vigabatrin oral solution, a $275M epilepsy drug, boosting its US generics and neurology portfolio.
Lupin Pharmaceuticals gets FDA approval for SOLOSEC sNDA
Lupin Pharmaceuticals has secured approval from the US Food and Drug Administration for its supplemental new drug application…